Shenzhen Weiguang Biological Products Co.Ltd(002880) : Announcement on the implementation progress of phase II ESOP

Securities code: 002880 securities abbreviation: Shenzhen Weiguang Biological Products Co.Ltd(002880) Announcement No.: 2022-005 Shenzhen Weiguang Biological Products Co.Ltd(002880)

Announcement on the implementation progress of phase II employee stock ownership plan

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.

The draft of the company’s shareholding plan and the second session of the 38th session of the board of directors (hereinafter referred to as “the summary”) were deliberated and adopted on October 21, 2021 and 2021 respectively, The first meeting of the third board of directors was held on December 9, 2021, and the proposal on extending the purchase period of the second phase of the company’s employee stock ownership plan was considered and adopted. The stock purchase period of the second phase of the company’s employee stock ownership plan will be extended for 6 months, that is, the purchase period will be extended before June 10, 2022. For details, please refer to the company’s designated media and cninfo (www.cn. Info. Com. CN.) on May 22, 2021, June 11, 2021 and December 10, 2021 Relevant announcements on.

In accordance with the guidance on the pilot implementation of ESOP by listed companies issued by the CSRC and the relevant provisions of the guidelines on self discipline supervision of listed companies No. 1 – standardized operation of listed companies on the main board issued by Shenzhen Stock Exchange, the implementation of the company’s phase II ESOP is hereby announced as follows:

As of the date of this announcement, the company has not purchased the company’s shares in the second phase of the employee stock ownership plan. The company will continue to pay attention to the progress of the implementation of the employee stock ownership plan and timely fulfill the obligation of information disclosure in accordance with relevant regulations.

It is hereby announced.

Shenzhen Weiguang Biological Products Co.Ltd(002880) board of directors February 9, 2022

- Advertisment -